Agios Pharmaceuticals | AGIO - 営業経費





営業経費 変化する 日付
AbbVie USD 10.52B 258M 2026-09
Agios Pharmaceuticals USD 155.3M 24.53M 2026-06
Alnylam Pharmaceuticals USD 1.11B 52.78M 2026-09
Amgen USD 5.69B 6B 2026-09
Arrowhead Research USD 245.35M 30.35M 2026-06
Astellas Pharma JPY 497.36B 41.8B 2026-09
AstraZeneca USD 11.55B 674M 2026-09
Bayer EUR 9.92B 121M 2026-09
Biogen USD 2.32B 663.6M 2026-09
BioMarin Pharmaceutical USD 819.04M 5.5B 2026-09
Bristol-Myers Squibb USD 23.4B 1.08B 2026-09
Daiichi Sankyo JPY 483.8B 5.85B 2026-09
Eli Lilly USD 10.52B 496M 2026-06
Exelixis USD 390.27M 10M 2026-09
Gilead Sciences USD 13.04B 9.09B 2026-09
GlaxoSmithKline GBP 6.03B 227M 2026-09
Incyte USD 5.64B 4.67B 2026-09
Ionis Pharmaceuticals USD 370.24M 6.24M 2026-06
Merck USD 10.75B 5.02B 2026-09
Moderna USD 1.18B 223M 2026-09
Nektar Therapeutics USD 49.12M 8.22M 2026-03
Novartis USD 9.88B 325M 2026-09
Novartis USD 13.19B 3.9B 2026-09
Pfizer USD 89B 3.81B 2026-09
Puma Biotechnology USD 49.26M 3.2M 2024-06
Regeneron Pharmaceuticals USD 33.5B 1.79B 2026-09
Roche Holding CHF 18.9B 2.12B 2026-06
Sarepta Therapeutics USD 390.39M 2.43M 2026-09
Vertex Pharmaceuticals USD 2.18B 118.2M 2026-09